Search the Newsreel

Northland Securities Maintains Nephros(NEPH.US) With Hold Rating, Raises Target Price to $4.75

Northland Securities has reiterated its Hold rating on Nephros (NEPH.US) but raised the price target to $4.75. This adjustment indicates a slightly more optimistic outlook on the company's future stock performance by the firm.

August 2026's Promising Penny Stocks

This article highlights three promising penny stocks for August 2026: Nephros (NEPH), Siebert Financial (SIEB), and Douglas Elliman (DOUG). It examines their financial health, recent performance, and strategic initiatives, noting that these companies offer potential for growth despite being smaller or newer entities. The …

Phreesia, Inc. (NYSE:PHR) Given Consensus Rating of "Hold" by Brokerages

Phreesia, Inc. (NYSE:PHR) has received a consensus "Hold" rating from 19 brokerages, with an average 12-month price target of $16.65. Recent analyst updates show mixed views, with some firms lowering price targets while others maintained buy ratings. The company's latest quarterly earnings exceeded expectations, …

Phreesia, Inc. $PHR Stake Lessened by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP reduced its stake in Phreesia, Inc. (NYSE:PHR) by 22.9% in the first quarter, selling 143,563 shares and retaining 484,717 shares valued at $4.07 million. Despite this reduction, institutional investors collectively own 92.1% of the company. Phreesia reported strong Q1 earnings …

AQR Capital discloses 5.1% Phreesia (PHR) ownership in new Schedule 13G

AQR Capital Management, LLC and AQR Capital Management Holdings, LLC have reported a beneficial ownership of 5.1% in Phreesia, Inc. (PHR) through a new Schedule 13G filing. This amounts to 3,151,453 shares of common stock, with both entities sharing voting and dispositive power. The …

NEPHROPLUS: Q1 FY 2027 delivered strong revenue and margin growth, with robust international expansion

NEPHROPLUS: Revenue grew 23.7% and adjusted EBITDA 31% year-on-year, with strong international expansion

Bronstein, Gewirtz & Grossman, LLC Is Investigating Phreesia, Inc. (PHR) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Phreesia, Inc. (NYSE: PHR) securities who bought prior to March 30, 2026, and still hold their shares. The investigation focuses on whether Phreesia and its officers/directors engaged in corporate wrongdoing. …

PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and its officers. The lawsuit, filed on behalf of investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026, alleges that the company made materially false …

Nephros (NEPH) boosts Q2 2026 profit on revenue growth and tariff refund

Nephros Inc. (NEPH) reported significant financial growth in Q2 2026, with net revenue up 36% to $6.0 million and net income rising to $1.2 million, largely driven by programmatic product growth and a $0.6 million IEEPA tariff refund. Despite this positive performance, the company …

Phreesia Inc (PHR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Phreesia Inc (PHR), detailing its current earnings forecast score, average price target from analysts, and a breakdown of analyst ratings. It also includes key financial figures such as expected revenue and EPS for upcoming quarters, alongside a …

Press Release: Nephros Announces Strong Financial Results for Quarter Ended June 30, 2026

Nephros announced strong financial results for the quarter ended June 30, 2026. The company reported significant revenue growth and improved profitability, driven by strong demand for its innovative filtration products. Management expressed optimism about future growth prospects and their ability to continue delivering value …

Nephros Inc (NEPH) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Nephros Inc (NEPH), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that three analysts rate NEPH as a "Buy" with an average price target of $7.00. The forecast also includes expected …

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Phreesia, Inc. (PHR) and Encourages Shareholders to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Phreesia, Inc. (NYSE:PHR) concerning potential corporate wrongdoing by the company and its officers/directors. The firm is encouraging shareholders who purchased Phreesia securities before March 30, 2026, and continue to hold them, to learn more …

Nephros Inc (NEPH) (Q2 2026) Earnings Call Highlights: Record Revenue and Profitability Surge ...

Nephros Inc (NEPH) reported record quarterly revenue of $6 million in Q2 2026, a 36% year-over-year increase, along with a significant surge in net income (over 400%) and Adjusted EBITDA (260%). The growth was attributed to broad-based improvements across product and service revenues, and …

Earnings call transcript: Nephros posts Q2 2026 growth, shares rise premarket

Nephros reported record revenue growth and stronger profitability in Q2 2026, with shares rising premarket despite a slight revenue miss. The company highlighted a 36% increase in revenue to $6.0 million and a significant rise in service-only revenue, driven by existing customers buying more …

Nephros says its service offerings nearly tripled during Q2

Nephros (Nasdaq: NEPH) reported record second-quarter 2026 net revenue of $6.0 million, a 36% increase year-over-year, with core programmatic revenue growing 27%. The company's service offerings nearly tripled compared to the prior year, reflecting increased customer demand for installation, replacement, and water management support. …

Phreesia Sets Release Date for Fiscal Second Quarter 2027 Results

ALL-REMOTE COMPANY/WILMINGTON, Del., August 06, 2026--(BUSINESS WIRE)--Phreesia, Inc. (NYSE: PHR) ("Phreesia") today announced that it will release its fiscal second quarter 2027 financial results after the close of market trading on Wednesday, Sept. 2, 2026. Phreesia will issue a press release announcing its quarterly …

Nephros Q2 2026 Earnings: Revenue Rises 36% as Tariff Refund Lifts Margins

Nephros reported a 36% increase in Q2 2026 net revenue to $6.017 million, with diluted EPS rising to $0.11, significantly boosted by a one-time $0.6 million tariff refund. While the refund inflated profitability, core programmatic revenue still grew 27%, and service-related revenue nearly tripled. …

Phreesia schedules Sept. 2 call to discuss fiscal Q2 results

Nephros to File Q2 Results After Close, Host 4:30 ET Call

Nephros (Nasdaq: NEPH) announced it will file its second-quarter 2026 financial results after market close on Thursday, August 06, 2026. The company will host a conference call on the same day at 4:30 p.m. ET. Dial-in details for domestic and international participants, along with …

Nephros Schedules Second Quarter 2026 Financial Results Conference Call

Nephros, Inc. announced it will file its second quarter financial results on Thursday, August 06, 2026, after market close and will host a conference call on the same day at 4:30 pm ET. The company is a leading water technology provider, offering filtration solutions …

PHR Stockholders Have Opportunity to Lead Phreesia, Inc. Class Ac

Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and certain officers, alleging federal securities law violations. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments …

PHREESIA, INC. (NYSE: PHR) SHAREHOLDER INVESTIGATION ALERT:

Bernstein Liebhard LLP is investigating potential breaches of fiduciary duty by directors and officers of Phreesia, Inc. (NYSE: PHR). The firm encourages current Phreesia shareholders who purchased shares before May 8, 2025, to contact them to learn about their legal rights. The investigation aims …

PHR Stockholders Have Rights – If You Lost Money Investing in Phreesia, Inc.

Robbins LLP has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased shares between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia misled investors about the sustainability of its Network Solutions business growth …

Phreesia, Inc. (PHR) Stock Analysis: Exploring a 23% Upside Potential Amid Robust Revenue Growth

Phreesia, Inc. (NYSE: PHR) director takes fee as 377 deferred stock units

Phreesia, Inc. director Lainie Goldstein received 377 deferred stock units (DSUs) on July 31, 2026, as an equity-based director fee in lieu of a cash retainer. These DSUs, valued at $10.73 per share, increase her direct holdings to 70,862 shares. The underlying common stock …

Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Phreesia, Inc. (NYSE: PHR). The firm is encouraging shareholders who purchased Phreesia securities before March 30, 2026, and continue to hold them, to contact them for more information and to …

How Phreesia Inc. (PHR) Affects Rotational Strategy Timing

This article analyzes Phreesia Inc. (PHR) using AI models to determine its impact on rotational strategy timing. It highlights key findings including shifting near-term sentiment, broader weak alignment, and compelling upside potential due to a lack of resistance levels. The analysis also provides three …

Nephros Inc (NEPH) Financial Health: Profitability & Balance Sheet Analysis

The article provides an analysis of Nephros Inc's (NEPH) financial health, noting its current financial score of 6.42, ranking 125 out of 159 in its industry. The company's financial status is described as robust, with low operating efficiency, and it recently reported a 6.87% …

Phreesia Number of Employees 2026 | Employee Count & Headcount Data

Phreesia, Inc. (PHR) had approximately 1,778 total employees worldwide as of March 2026, marking a 7.1% decline from 1,914 employees in 2023. The company, which is in the Biotech and Healthcare Services industry, is actively hiring with 57 job postings in 2026, despite a …

Nephros Inc (NEPH) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Nephros Inc (NEPH), detailing its current valuation score, P/E ratio, and market data. It highlights that the company's valuation score is 8.25, placing it 75th in its industry, and notes its P/E ratio of 46.43. The analysis …

Nephros Inc (NEPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Nephros Inc (NEPH), detailing its current price momentum score, identified support and resistance levels, and a summary of technical indicators and moving averages. According to the analysis, the stock is currently trading between $3.66 (resistance) and $3.01 …